QuickView for PRAF2 (gene)

1. Control of CCR5 Cell-Surface Targeting by the PRAF2 Gatekeeper.
2. Pharmacological chaperone-rescued cystic fibrosis CFTR-F508del mutant overcomes PRAF2-gated access t…
3. Prolonged Beneficial Effect of Brief Erythropoietin Peptide JM4 Therapy on Chronic Relapsing EAE.
4. PRAF2 expression indicates unfavorable clinical outcome in hepatocellular carcinoma.
5. JHDM1D-AS1 aggravates the development of gastric cancer through miR-450a-2-3p-PRAF2 axis.

There were no clinical trials for PRAF2